HiCM-188 therapy

BIOLOGICAL2 trials

Sponsors

Help Therapeutics, HELP Therapeutics Co., Ltd.

Conditions

Heart Failure

Phase 1

Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure

Active, not recruitingNCT06340048

Help TherapeuticsHeart Failure

Start: 2023-09-05End: 2027-05-10Target: 36Updated: 2026-02-10

Phase 3

A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)

RecruitingNCT07496372

HELP Therapeutics Co., Ltd.Heart Failure

Start: 2026-04-30End: 2027-08-31Target: 80Updated: 2026-05-12